| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
|
Jewell, Jennifer
|
|
|
|
3 |
p. 197-203
|
artikel
|
| 2 |
Adherence to Adjuvant Endocrine Therapy and Survival Among Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
|
Park, Chanhyun
|
|
|
|
3 |
p. 167-176
|
artikel
|
| 3 |
Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS
|
Ji, Huan-huan
|
|
2019
|
|
3 |
p. 319-330
|
artikel
|
| 4 |
A Fatal Case of Bictegravir-Induced Fulminant Hepatic Failure
|
Sanchez, Jacob Louis
|
|
|
|
3 |
p. 205-208
|
artikel
|
| 5 |
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury
|
Das, Saibal
|
|
2017
|
|
3 |
p. 211-218
|
artikel
|
| 6 |
An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19
|
Homolak, Jan
|
|
|
|
3 |
p. 287-289
|
artikel
|
| 7 |
Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B- Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy
|
Meno, Hiroshi
|
|
2012
|
|
3 |
p. 171-178
|
artikel
|
| 8 |
A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients
|
Moore, David J.
|
|
2012
|
|
3 |
p. 179-187
|
artikel
|
| 9 |
A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid
|
Nor, Norazirah Md
|
|
2016
|
|
3 |
p. 295-301
|
artikel
|
| 10 |
A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
|
Hu, Yifan
|
|
2017
|
|
3 |
p. 191-199
|
artikel
|
| 11 |
A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects
|
Jing, Shan
|
|
|
|
3 |
p. 155-165
|
artikel
|
| 12 |
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting
|
Hasvold, Pål
|
|
2015
|
|
3 |
p. 225-233
|
artikel
|
| 13 |
Association of First- vs. Second-Generation Antipsychotics with Lipid Abnormalities in Individuals with Severe Mental Illness: A Systematic Review and Meta-Analysis
|
Buhagiar, Kurt
|
|
2019
|
|
3 |
p. 253-273
|
artikel
|
| 14 |
Atorvastatin versus Bezafibrate in Mixed Hyperlipidaemia
|
Ros, Emilio
|
|
|
|
3 |
p. 153-165
|
artikel
|
| 15 |
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
2017
|
|
3 |
p. 279-285
|
artikel
|
| 16 |
Cannabidiol in the Treatment of Epilepsy
|
von Wrede, Randi
|
|
|
|
3 |
p. 211-220
|
artikel
|
| 17 |
Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis
|
Yamamoto, Toshiyuki
|
|
2019
|
|
3 |
p. 241-252
|
artikel
|
| 18 |
Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects
|
Jain, Shilpi
|
|
|
|
3 |
p. 259-268
|
artikel
|
| 19 |
Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”
|
van Oosterom, Nameer
|
|
|
|
3 |
p. 287-288
|
artikel
|
| 20 |
Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
|
Quercia, Romina
|
|
2015
|
|
3 |
p. 211-219
|
artikel
|
| 21 |
Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations
|
Shah, Nina
|
|
|
|
3 |
p. 201-210
|
artikel
|
| 22 |
Comparative Pharmacokinetics and Bioavailability of Gemifloxacin Administered as an Intravenous 200 mg Formulation or an Oral 320 mg Tablet
|
Kim, Mi Jo
|
|
2013
|
|
3 |
p. 195-201
|
artikel
|
| 23 |
Comparison of Dexketoprofen Trometamol and Dipyrone in the Treatment of Renal Colic
|
Sánchez-Carpena, Juan
|
|
|
|
3 |
p. 139-152
|
artikel
|
| 24 |
Comparison of Real-World Costs, Healthcare Resource Utilization, and Comorbidity-Related Costs Between Ixekizumab and Secukinumab Among Biologic-Experienced Patients with Psoriasis Over 18 Months in the USA
|
Blauvelt, Andrew
|
|
|
|
3 |
p. 185-196
|
artikel
|
| 25 |
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
|
Baraliakos, Xenofon
|
|
|
|
3 |
p. 269-278
|
artikel
|
| 26 |
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial
|
Salehifar, Ebrahim
|
|
|
|
3 |
p. 249-257
|
artikel
|
| 27 |
Comparison of the Influence of Cyclosporine and Tacrolimus on the Pharmacokinetics of Prednisolone in Adult Male Kidney Transplant Recipients
|
Bergmann, Troels K.
|
|
2013
|
|
3 |
p. 183-188
|
artikel
|
| 28 |
Correction to: Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit
|
Kumar, Sanjay
|
|
|
|
3 |
p. 281-282
|
artikel
|
| 29 |
Correction to: Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non‑Asian Patients with Atrial Fibrillation: A Systematic Review and Meta‑Analysis
|
Escobar, Carlos
|
|
|
|
3 |
p. 279-280
|
artikel
|
| 30 |
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
|
Tepper, Stewart J.
|
|
|
|
3 |
p. 277
|
artikel
|
| 31 |
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma
|
Ryoo, Baek‑Yeol
|
|
|
|
3 |
p. 283
|
artikel
|
| 32 |
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
|
Lyseng-Williamson, Katherine A.
|
|
|
|
3 |
p. 291
|
artikel
|
| 33 |
Correction to: Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
|
Isakov, Vasily
|
|
|
|
3 |
p. 291
|
artikel
|
| 34 |
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies
|
Pecoraro, Antonio
|
|
|
|
3 |
p. 279-286
|
artikel
|
| 35 |
Correlations Between SGLT-2 Inhibitors and Acute Renal Failure by Signal Detection Using FAERS: Stratified Analysis for Reporting Country and Concomitant Drugs
|
Katsuhara, Yukari
|
|
|
|
3 |
p. 235-243
|
artikel
|
| 36 |
Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China
|
Zhang, Chi
|
|
2015
|
|
3 |
p. 197-209
|
artikel
|
| 37 |
Cost-Effectiveness Analysis of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation in Taiwan
|
Liu, Chieh-Yu
|
|
2016
|
|
3 |
p. 285-293
|
artikel
|
| 38 |
Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System
|
Lang, Wenwang
|
|
|
|
3 |
p. 149-162
|
artikel
|
| 39 |
Cost-Effectiveness Comparison Between the Response-Guided Therapies and Monotherapies of Nucleos(t)ide Analogues for Chronic Hepatitis B Patients in China
|
Lai, Keng
|
|
2016
|
|
3 |
p. 233-247
|
artikel
|
| 40 |
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model
|
Thaliffdeen, Ryan
|
|
|
|
3 |
p. 209-217
|
artikel
|
| 41 |
Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available “Real-World” Evidence: The Italian National Health System Perspective
|
Lorenzoni, Valentina
|
|
|
|
3 |
p. 255-267
|
artikel
|
| 42 |
Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany
|
Erhardt, Wilma
|
|
2012
|
|
3 |
p. 189-202
|
artikel
|
| 43 |
Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China
|
Xu, Yan
|
|
2019
|
|
3 |
p. 331-340
|
artikel
|
| 44 |
Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial
|
Takumoto, Yuki
|
|
|
|
3 |
p. 253-262
|
artikel
|
| 45 |
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection
|
Lodise, Thomas P.
|
|
|
|
3 |
p. 269-275
|
artikel
|
| 46 |
Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?
|
Wynberg, Elke
|
|
2017
|
|
3 |
p. 231-238
|
artikel
|
| 47 |
Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects
|
Dingemanse, Jasper
|
|
2013
|
|
3 |
p. 207-213
|
artikel
|
| 48 |
Drug Interactions with Levothyroxine Therapy in Patients with Hypothyroidism: Observational Study in General Practice
|
Trifirò, Gianluca
|
|
2015
|
|
3 |
p. 187-195
|
artikel
|
| 49 |
Effect of Add-on Pentoxifylline on Proteinuria in Membranous Glomerulonephritis: A 6-month Placebo-controlled Trial
|
Badri, Shirinsadat
|
|
2013
|
|
3 |
p. 215-222
|
artikel
|
| 50 |
Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone
|
Grönlund, Juha
|
|
2011
|
|
3 |
p. 143-153
|
artikel
|
| 51 |
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study
|
Jenkins, Helen
|
|
2016
|
|
3 |
p. 311-316
|
artikel
|
| 52 |
Effect of Quetiapine and Norquetiapine on Anxiety and Depression in Major Psychoses Using a Pharmacokinetic Approach
|
Altamura, A. Carlo
|
|
2012
|
|
3 |
p. 213-219
|
artikel
|
| 53 |
Effect of Ticagrelor versus Clopidogrel on All-Cause and Cardiovascular Mortality in Acute Coronary Syndrome Patients with Hyperuricemia
|
Nie, Shanshan
|
|
|
|
3 |
p. 163-174
|
artikel
|
| 54 |
Effects of D-003, a New Hypocholesterolaemic and Antiplatelet Compound, on Lipid Profile and Lipid Peroxidation in Healthy Volunteers
|
Castaño, Gladys
|
|
|
|
3 |
p. 193-203
|
artikel
|
| 55 |
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
|
Tepper, Stewart J.
|
|
|
|
3 |
p. 263-275
|
artikel
|
| 56 |
Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome
|
Martinez-Martin, Francisco J.
|
|
2011
|
|
3 |
p. 201-212
|
artikel
|
| 57 |
Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics
|
Yin, Ophelia Q.P.
|
|
2011
|
|
3 |
p. 169-179
|
artikel
|
| 58 |
Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting
|
Ekesbo, Rickard
|
|
2011
|
|
3 |
p. 181-189
|
artikel
|
| 59 |
Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials
|
Rognoni, Carla
|
|
2015
|
|
3 |
p. 177-194
|
artikel
|
| 60 |
Efficacy and Safety of Sublingual Fentanyl Tablets for the Management of Breakthrough Pain in Patients with Chronic Musculoskeletal Pain with Neuropathic Component: Multicenter Prospective Study
|
Cánovas-Martínez, Luz
|
|
2015
|
|
3 |
p. 169-177
|
artikel
|
| 61 |
Efficacy and Safety of 1 % Terbinafine Film-Forming Solution in Chinese Patients with Tinea Pedis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study
|
Li, Ruo Yu
|
|
2014
|
|
3 |
p. 223-230
|
artikel
|
| 62 |
Efficacy of Off-Label Topical Treatments for the Management of Androgenetic Alopecia: A Review
|
Gupta, Aditya K.
|
|
2019
|
|
3 |
p. 233-239
|
artikel
|
| 63 |
Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL
|
Ehinger, Karl Henrik Johannes
|
|
2013
|
|
3 |
p. 231
|
artikel
|
| 64 |
Erratum to: Efficacy and Tolerability of Once-Daily Grepafloxacin Compared with Clarithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
|
DeAbate, C. Andrew
|
|
1999
|
|
3 |
p. 243-253
|
artikel
|
| 65 |
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database
|
Kanbayashi, Yuko
|
|
|
|
3 |
p. 177-184
|
artikel
|
| 66 |
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers
|
Salem, Ahmed Hamed
|
|
2016
|
|
3 |
p. 303-309
|
artikel
|
| 67 |
Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects
|
Bouhajib, Mohammed
|
|
2019
|
|
3 |
p. 309-317
|
artikel
|
| 68 |
Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies
|
Nagai, Kota
|
|
|
|
3 |
p. 197-209
|
artikel
|
| 69 |
Factors Related to the Glucose-Lowering Efficacy of Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Meta-Analysis Focusing on Ethnicity and Study Regions
|
Fujita, Kayo
|
|
2016
|
|
3 |
p. 219-232
|
artikel
|
| 70 |
Fidaxomicin in the Treatment of Clostridium difficile-Associated Diarrhoea
|
Sclar, David Alexander
|
|
2013
|
|
3 |
p. 229
|
artikel
|
| 71 |
Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex
|
Kam, Pieter-Jan de
|
|
2012
|
|
3 |
p. 203-212
|
artikel
|
| 72 |
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study
|
Fukase, Hiroyuki
|
|
|
|
3 |
p. 237-247
|
artikel
|
| 73 |
Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance
|
Colina, Matteo
|
|
|
|
3 |
p. 141-148
|
artikel
|
| 74 |
HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
|
Murrell, Derek E.
|
|
2019
|
|
3 |
p. 285-299
|
artikel
|
| 75 |
17 α-Hydroxyprogesterone Caproate (Makena®)
|
Hines, Mary
|
|
2013
|
|
3 |
p. 223-227
|
artikel
|
| 76 |
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study
|
Charles, Cécile
|
|
2016
|
|
3 |
p. 235-242
|
artikel
|
| 77 |
Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease
|
Iwashima, Satoru
|
|
2011
|
|
3 |
p. 191-199
|
artikel
|
| 78 |
Improved Efficacy of Intramuscular Weekly Administration of Clodronate 200 mg (100 mg Twice Weekly) Compared with 100 mg (Once Weekly) for Increasing Bone Mineral Density in Postmenopausal Osteoporosis
|
Frediani, Bruno
|
|
2013
|
|
3 |
p. 193-198
|
artikel
|
| 79 |
Increased Warfarin Sensitivity Complicated by Retroperitoneal Haemorrhage in a Patient with Merkel Cell Carcinoma
|
Margolin, L.
|
|
|
|
3 |
p. 217-218
|
artikel
|
| 80 |
Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
|
Isakov, Vasily
|
|
2017
|
|
3 |
p. 239-247
|
artikel
|
| 81 |
Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
|
Isakov, Vasily
|
|
|
|
3 |
p. 239-247
|
artikel
|
| 82 |
Lithium Toxicity in Older Adults: a Systematic Review of Case Reports
|
Sun, Meng
|
|
2017
|
|
3 |
p. 201-209
|
artikel
|
| 83 |
Management Options for Gynaecomastia and Breast Pain Associated with Nonsteroidal Antiandrogen Therapy
|
Leibovitch, I.
|
|
|
|
3 |
p. 205-215
|
artikel
|
| 84 |
Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study
|
Yang, Jin-Kui
|
|
2013
|
|
3 |
p. 185-191
|
artikel
|
| 85 |
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
|
Hoertel, Nicolas
|
|
|
|
3 |
p. 221-233
|
artikel
|
| 86 |
Omadacycline Oral Dosing and Pharmacokinetics in Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infection
|
Leviton, Ira M.
|
|
|
|
3 |
p. 193-197
|
artikel
|
| 87 |
Omalizumab for Difficult-to-Treat Dermatological Conditions: Clinical and Immunological Features from a Retrospective Real-Life Experience
|
Romano, Ciro
|
|
2015
|
|
3 |
p. 159-168
|
artikel
|
| 88 |
One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease
|
Brazinsky, Shari A.
|
|
|
|
3 |
p. 181-191
|
artikel
|
| 89 |
Onset of Action of Formoterol versus Salmeterol via Dry Powder Inhalers in Moderate Chronic Obstructive Pulmonary Disease
|
Cazzola, Mario
|
|
2012
|
|
3 |
p. 147-155
|
artikel
|
| 90 |
Opioid Use and Pain Control in the Elderly After Elective or Urgent Orthopaedic Surgery: A Retrospective Cohort Study
|
Dagenais-Beaulé, Vincent
|
|
2019
|
|
3 |
p. 301-308
|
artikel
|
| 91 |
Pathway to Clozapine Use: A Comparison Between a Patient Cohort from New Zealand and a Cohort from the United Kingdom
|
Wheeler, Amanda J.
|
|
2014
|
|
3 |
p. 203-211
|
artikel
|
| 92 |
Pharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir
|
Wind, Sven
|
|
2014
|
|
3 |
p. 173-182
|
artikel
|
| 93 |
Pharmacokinetic-Pharmacodynamic Modelling of Recombinant Human Erythropoietin in Athletes
|
Gaudard, A.
|
|
|
|
3 |
p. 167-179
|
artikel
|
| 94 |
Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers
|
Rice, David
|
|
2017
|
|
3 |
p. 249-257
|
artikel
|
| 95 |
Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus
|
Yong, Xiaolan
|
|
2015
|
|
3 |
p. 195-202
|
artikel
|
| 96 |
Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis
|
Lain, Edward
|
|
2017
|
|
3 |
p. 249-257
|
artikel
|
| 97 |
Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects
|
Raffa, Robert B.
|
|
2017
|
|
3 |
p. 259-268
|
artikel
|
| 98 |
Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers
|
Nichols, Alice I.
|
|
2011
|
|
3 |
p. 155-167
|
artikel
|
| 99 |
Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
|
Boinpally, Ramesh
|
|
2013
|
|
3 |
p. 199-206
|
artikel
|
| 100 |
Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density
|
Miller, Paul D.
|
|
|
|
3 |
p. 277-285
|
artikel
|
| 101 |
Population Pharmacokinetic Modeling of Tapentadol Extended Release (ER) in Healthy Subjects and Patients with Moderate or Severe Chronic Pain
|
Huntjens, Dymphy R.
|
|
2016
|
|
3 |
p. 213-223
|
artikel
|
| 102 |
Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports
|
Martínez-Cuadrón, David
|
|
|
|
3 |
p. 227-235
|
artikel
|
| 103 |
Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients
|
Ibiloye, Elizabeth A.
|
|
|
|
3 |
p. 245-253
|
artikel
|
| 104 |
Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
|
|
3 |
p. 269-278
|
artikel
|
| 105 |
Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
2017
|
|
3 |
p. 269-278
|
artikel
|
| 106 |
Quantifying the Exposure of Tapentadol Extended Release in Japanese Patients with Cancer Pain and Bridging Tapentadol Pharmacokinetics Across Populations Using a Modeling Approach
|
Zhang, Liping
|
|
2016
|
|
3 |
p. 273-283
|
artikel
|
| 107 |
Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers
|
Schoedel, Kerri A.
|
|
2012
|
|
3 |
p. 157-169
|
artikel
|
| 108 |
Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women
|
Radicioni, Milko
|
|
|
|
3 |
p. 199-206
|
artikel
|
| 109 |
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)
|
Bell, Christopher F.
|
|
|
|
3 |
p. 183-198
|
artikel
|
| 110 |
Relative Cardiovascular and Gastrointestinal Safety of Non-selective Non-steroidal Anti-inflammatory Drugs Versus Cyclo-oxygenase-2 Inhibitors
|
Patrício, José Pedro Henriques
|
|
2013
|
|
3 |
p. 167-183
|
artikel
|
| 111 |
Response to Comment on: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”
|
Lee, Young R.
|
|
|
|
3 |
p. 289-290
|
artikel
|
| 112 |
Risk Factors for Acute Kidney Injury in Adult Patients Receiving Vancomycin
|
Cappelletty, Diane
|
|
2013
|
|
3 |
p. 189-193
|
artikel
|
| 113 |
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme
|
Kimutai, Robert
|
|
2017
|
|
3 |
p. 259-272
|
artikel
|
| 114 |
Safety and Efficacy of Biologic Medications and Janus Kinase Inhibitors in Patients with Down Syndrome: A Retrospective Cohort Study
|
Westerkam, Linnea
|
|
|
|
3 |
p. 219-222
|
artikel
|
| 115 |
Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center
|
Wang, Felicia Y.
|
|
|
|
3 |
p. 175-181
|
artikel
|
| 116 |
Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy
|
Kadoglou, Nikolaos P. E.
|
|
2013
|
|
3 |
p. 165-171
|
artikel
|
| 117 |
Significant Correlations between p-Cresol Sulfate and Mycophenolic Acid Plasma Concentrations in Adult Kidney Transplant Recipients
|
Rong, Yan
|
|
|
|
3 |
p. 207-219
|
artikel
|
| 118 |
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Limaprost in Healthy Chinese Subjects
|
Chen, Hong
|
|
2015
|
|
3 |
p. 151-157
|
artikel
|
| 119 |
Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study
|
Vultaggio, Alessandra
|
|
2015
|
|
3 |
p. 179-185
|
artikel
|
| 120 |
Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report)
|
Takahashi, Tomohiko
|
|
2017
|
|
3 |
p. 219-229
|
artikel
|
| 121 |
Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis
|
Carrillo-Aleman, Luna
|
|
2019
|
|
3 |
p. 275-283
|
artikel
|
| 122 |
Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients
|
Di Nunno, Vincenzo
|
|
|
|
3 |
p. 211-226
|
artikel
|
| 123 |
The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study
|
Avanceña, Anton L. V.
|
|
|
|
3 |
p. 243-252
|
artikel
|
| 124 |
The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib
|
Piscitelli, Joseph
|
|
|
|
3 |
p. 221-235
|
artikel
|
| 125 |
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
|
Marcellusi, Andrea
|
|
|
|
3 |
p. 237-242
|
artikel
|
| 126 |
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy
|
Trifirò, Gianluca
|
|
2015
|
|
3 |
p. 203-212
|
artikel
|
| 127 |
The Pharmacokinetic and Safety Profiles of Blonanserin in Healthy Chinese Volunteers After Single Fasting Doses and Single and Multiple Postprandial Doses
|
Chen, Xia
|
|
2014
|
|
3 |
p. 213-222
|
artikel
|
| 128 |
The Safety of Melatonin in Humans
|
Andersen, Lars Peter Holst
|
|
2015
|
|
3 |
p. 169-175
|
artikel
|
| 129 |
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database
|
Yang, Xiongwen
|
|
|
|
3 |
p. 199-207
|
artikel
|
Tijdschrift beschrijving